VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Methyl prednisolone
Phase 3
Small molecule
N
Nucitec
1
Indications
10
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Vasculitis
1 trial
Plasma Exchange for Renal Vasculitis
Terminated
·
—
·
Phase 2/3
·
NCT01408836
·
150 enrolled
Treatment
1 trial
Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment
Unknown status
·
N
Nucitec
·
Phase 2/3
·
NCT00977444
·
114 enrolled
Pediatric Patients
1 trial
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
Completed
·
K
Konya City Hospital
·
N/A
·
NCT07175623
·
60 enrolled
Complication
1 trial
Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications
Enrolling by invitation
·
S
Sana'a University
·
Phase 3
·
NCT07317596
·
40 enrolled
Histiocytosis
1 trial
Treatment of Familiar Lymphohistiocytosis
Completed
·
A
Assistance Publique - Hôpitaux de Paris
·
Phase 1/2
·
NCT02472054
·
29 enrolled
5 more indications
Clinical Trial
1 trial
PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial
Completed
·
K
Kristian Kiim Jensen
·
N/A
·
NCT02594241
·
42 enrolled
Lupus Nephritis
1 trial
Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Terminated
·
I
Imperial College London
·
Phase 3
·
NCT01773616
·
24 enrolled
Neuropathy
1 trial
Traumatic Optic Neuropathy Treatment Trial (TONTT)
Completed
·
T
Tehran University of Medical Sciences
·
Phase 1/2
·
NCT01783847
·
117 enrolled
Lymphoma
1 trial
Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Completed
·
M
M.D. Anderson Cancer Center
·
Phase 3
·
NCT00577993
·
210 enrolled
Heart Disease
1 trial
High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease
Unknown status
·
—
·
Phase 4
·
NCT05103397
·
75 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
10 trial records for Methyl prednisolone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Methyl prednisolone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Methyl prednisolone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Nucitec company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
N
Nucitec
Related News